Form D · Biotechnology

AgilVax, Inc.

Albuquerque, NM · CIK 0001610522

Offering snapshot reported Aug 28, 2019 · SEC filing

Reported sold: $3M
Investors reported: 2
Minimum accepted: $100K
First sale: Apr 27, 2018

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$500,000 → $3,000,000

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Aug 28, 2019	Amendment	$3,000,000	$2,500,000vs May 10, 2018	2	SEC filing
May 10, 2018	Initial	$500,000	No comparison	2	SEC filing
Jun 12, 2014	Initial	$1,150,000	No comparison	4	SEC filing

Offering details

Securities: Equity
Exemptions: 06b
Duration over one year: Yes
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-312079

Source: Form D, filed Aug 28, 2019. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Brian Birk	Director, Executive
Dee Brescia	Executive
Faith Charles	Director
Bill Enloe	Director
Ebetuel Pallares	Director, Executive
Joseph Patti	Director, Executive
Federica Pericle	Director, Executive
Debora E Ramirez	Executive
Stuart Rose	Director
Waneta Tuttle	Director
Brad Vale	Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:

5901 Indian School Road Ne
Albuquerque, NM, 87110